Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of 57.05 billion. The enterprise value is 66.29 billion.
| Market Cap | 57.05B |
| Enterprise Value | 66.29B |
Important Dates
The last earnings date was Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | Apr 28, 2025 |
Share Statistics
| Current Share Class | 129.24M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 129.24M |
Valuation Ratios
The trailing PE ratio is 16.97 and the forward PE ratio is 12.85.
| PE Ratio | 16.97 |
| Forward PE | 12.85 |
| PS Ratio | 2.29 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 9.11 |
| P/FCF Ratio | 22.46 |
| P/OCF Ratio | 12.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.51, with an EV/FCF ratio of 26.10.
| EV / Earnings | 19.72 |
| EV / Sales | 2.67 |
| EV / EBITDA | 9.51 |
| EV / EBIT | 13.29 |
| EV / FCF | 26.10 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.24 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | 4.35 |
| Interest Coverage | 17.75 |
Financial Efficiency
Return on equity (ROE) is 10.10% and return on invested capital (ROIC) is 6.91%.
| Return on Equity (ROE) | 10.10% |
| Return on Assets (ROA) | 5.48% |
| Return on Invested Capital (ROIC) | 6.91% |
| Return on Capital Employed (ROCE) | 11.36% |
| Revenue Per Employee | 394,546 |
| Profits Per Employee | 53,235 |
| Employee Count | 59,020 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.91 |
Taxes
In the past 12 months, Merck KGaA has paid 897.24 million in taxes.
| Income Tax | 897.24M |
| Effective Tax Rate | 20.99% |
Stock Price Statistics
The stock price has decreased by -28.73% in the last 52 weeks. The beta is 0.63, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -28.73% |
| 50-Day Moving Average | 130.61 |
| 200-Day Moving Average | 140.73 |
| Relative Strength Index (RSI) | 56.09 |
| Average Volume (20 Days) | 1,219 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of 24.92 billion and earned 3.36 billion in profits. Earnings per share was 7.74.
| Revenue | 24.92B |
| Gross Profit | 14.63B |
| Operating Income | 5.00B |
| Pretax Income | 4.27B |
| Net Income | 3.36B |
| EBITDA | 6.99B |
| EBIT | 5.00B |
| Earnings Per Share (EPS) | 7.74 |
Balance Sheet
The company has 1.85 billion in cash and 11.04 billion in debt, giving a net cash position of -9.19 billion.
| Cash & Cash Equivalents | 1.85B |
| Total Debt | 11.04B |
| Net Cash | -9.19B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 33.27B |
| Book Value Per Share | 76.35 |
| Working Capital | 2.74B |
Cash Flow
In the last 12 months, operating cash flow was 4.48 billion and capital expenditures -1.94 billion, giving a free cash flow of 2.54 billion.
| Operating Cash Flow | 4.48B |
| Capital Expenditures | -1.94B |
| Free Cash Flow | 2.54B |
| FCF Per Share | n/a |
Margins
Gross margin is 58.69%, with operating and profit margins of 20.08% and 13.49%.
| Gross Margin | 58.69% |
| Operating Margin | 20.08% |
| Pretax Margin | 17.15% |
| Profit Margin | 13.49% |
| EBITDA Margin | 28.06% |
| EBIT Margin | 20.08% |
| FCF Margin | 10.19% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 1.92%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 1.92% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.29% |
| Buyback Yield | 0.15% |
| Shareholder Yield | 2.08% |
| Earnings Yield | 5.89% |
| FCF Yield | 4.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck KGaA has an Altman Z-Score of 3.44 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.44 |
| Piotroski F-Score | 7 |